HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin resistance in 3T3-L1 adipocytes by TNF-α is improved by punicic acid through upregulation of insulin signalling pathway and endocrine function, and downregulation of proinflammatory cytokines.

Abstract
Insulin resistance (IR) has become a major threat to public health due to its role in metabolic syndrome. Inflammation associated with IR is an interesting area of biomedical research in recent years and is expected to affect insulin signalling pathway via downregulating glucose transporters. In the present study, we evaluate the potential of punicic acid (PA), a nutraceutical found in pomegranate seed oil, against TNF-α induced alteration in 3T3-L1 adipocytes on glucose metabolism, endocrine function and inflammation. IR was induced in 3T3-L1 adipocytes by treating with TNF-α (10 ng/mL) and various concentrations of PA (5, 10, 30 μM) were incubated simultaneously. After 24 h, we found that TNF-α treatment increased mRNA expression of SOCS3, PTP1B and a decrease in IRS1 causing diminished glucose uptake. Further, it showed significantly increased transcriptional activity of NFκB and leptin secretion while PA maintained leptin levels normal. Additionally, PA prevented the over-expression of phosphorylated JNK in a dose dependent manner during IR. PA also ameliorated significantly the upregulation of proinflammatory cytokines. From the results, we conclude that PA is effective to ameliorate TNF-α induced IR and also we recommend the intake of PA for control and management of IR and its associated complications.
AuthorsS S Anusree, G Sindhu, M R Preetha Rani, K G Raghu
JournalBiochimie (Biochimie) Vol. 146 Pg. 79-86 (Mar 2018) ISSN: 1638-6183 [Electronic] France
PMID29180021 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.
Chemical References
  • Adiponectin
  • Cytokines
  • Glucose Transporter Type 4
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Leptin
  • Linolenic Acids
  • PPAR gamma
  • RNA, Messenger
  • Suppressor of Cytokine Signaling 3 Protein
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • JNK Mitogen-Activated Protein Kinases
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Ptpn1 protein, mouse
  • Glucose
  • punicic acid
Topics
  • 3T3-L1 Cells
  • Adipocytes (cytology, drug effects, metabolism)
  • Adiponectin (metabolism)
  • Animals
  • Biological Transport (drug effects)
  • Cytokines (metabolism)
  • Drug Synergism
  • Glucose (metabolism)
  • Glucose Transporter Type 4 (genetics, metabolism)
  • Inflammation (metabolism)
  • Insulin
  • Insulin Receptor Substrate Proteins (metabolism)
  • Insulin Resistance
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Leptin (metabolism)
  • Linolenic Acids (pharmacology)
  • Mice
  • PPAR gamma (metabolism)
  • Phosphorylation (drug effects)
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 (metabolism)
  • RNA, Messenger (genetics, metabolism)
  • Signal Transduction (drug effects)
  • Suppressor of Cytokine Signaling 3 Protein (metabolism)
  • Transcription Factor RelA (metabolism)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: